At a glance
ClinicalIndex Comparison RecordN/ACompleted· 296 enrolled
Drug / intervention
Floredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Customized Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
In Brief
A clinical study evaluating Flore for Autism Spectrum Disorder. Completed, enrolled 296 participants across 1 site.
Detailed Summary
This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesUnited States
CollaboratorsSun Genomics
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
First PostedDec 2020
Primary CompletionMay 2025
Study CompletionJul 2025
TodayJul 2026
First PostedDec 7, 2020
Enrollment StartOct 15, 2020
Primary CompletionMay 15, 2025
Study CompletionJul 12, 2025
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 5.6 years ago
Interventions
Floredietary
personalized blend of GRAS approved probiotic strains, prebiotics, and botanicals